NO20035331D0 - Nye heterocyklisk forbindelse og medisinsk anvendelse derav - Google Patents

Nye heterocyklisk forbindelse og medisinsk anvendelse derav

Info

Publication number
NO20035331D0
NO20035331D0 NO20035331A NO20035331A NO20035331D0 NO 20035331 D0 NO20035331 D0 NO 20035331D0 NO 20035331 A NO20035331 A NO 20035331A NO 20035331 A NO20035331 A NO 20035331A NO 20035331 D0 NO20035331 D0 NO 20035331D0
Authority
NO
Norway
Prior art keywords
heterocyclic compounds
medical use
new heterocyclic
new
medical
Prior art date
Application number
NO20035331A
Other languages
English (en)
Other versions
NO326688B1 (no
Inventor
Hiroshi Matsui
Hideo Kobayashi
Satoru Azukizawa
Masayasu Kasai
Akihisa Yoshimi
Hiroaki Shirahase
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of NO20035331D0 publication Critical patent/NO20035331D0/no
Publication of NO326688B1 publication Critical patent/NO326688B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20035331A 2001-05-29 2003-11-28 Heterocyklisk forbindelse og anvendelse av denne, samt farmasoytisk sammensetning omfattende forbindelsen NO326688B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001161489 2001-05-29
PCT/JP2002/005097 WO2002096880A1 (fr) 2001-05-29 2002-05-27 Nouveau compose heterocyclique et son utilisation medicinale

Publications (2)

Publication Number Publication Date
NO20035331D0 true NO20035331D0 (no) 2003-11-28
NO326688B1 NO326688B1 (no) 2009-01-26

Family

ID=19004756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035331A NO326688B1 (no) 2001-05-29 2003-11-28 Heterocyklisk forbindelse og anvendelse av denne, samt farmasoytisk sammensetning omfattende forbindelsen

Country Status (23)

Country Link
US (1) US7557123B2 (no)
EP (1) EP1403253A4 (no)
JP (1) JP4279136B2 (no)
KR (2) KR20040030647A (no)
CN (1) CN1242994C (no)
AR (1) AR036036A1 (no)
AU (1) AU2002308889B2 (no)
BR (1) BR0209711A (no)
CA (1) CA2448634A1 (no)
CO (1) CO5540342A2 (no)
CZ (1) CZ20033450A3 (no)
HK (1) HK1069385A1 (no)
HU (1) HUP0401862A3 (no)
IL (1) IL159085A0 (no)
MX (1) MXPA03010811A (no)
NO (1) NO326688B1 (no)
NZ (1) NZ530358A (no)
PL (1) PL367639A1 (no)
RU (1) RU2299197C2 (no)
TW (1) TWI297008B (no)
WO (1) WO2002096880A1 (no)
YU (1) YU94003A (no)
ZA (1) ZA200309757B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU94203A (sh) 2001-05-29 2006-08-17 Kyoto Pharmaceutical Industries Ltd. Novi heterociklični derivati i njihova upotreba u medicini
US7816385B2 (en) * 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US7718377B2 (en) 2003-05-29 2010-05-18 Kyoto Pharmaceutical Industries, Ltd. Insulin resistance curative and method of screening the same
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
US7790745B2 (en) * 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
WO2007058504A1 (en) * 2005-11-21 2007-05-24 Lg Life Sciences, Ltd. Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same
JPWO2012033195A1 (ja) * 2010-09-10 2014-01-20 京都薬品工業株式会社 複素環化合物
CN102807526B (zh) * 2011-06-21 2015-12-02 寿光富康制药有限公司 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ptp-1b阻害剤およびその用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
DE10199003I1 (de) * 1987-09-04 2003-06-12 Beecham Group Plc Substituierte Thiazolidinionderivate
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
AU3719997A (en) 1996-07-01 1998-01-21 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
EP1019378B1 (en) * 1996-07-01 2004-09-29 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
GB9817118D0 (en) 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
IL149883A0 (en) * 1999-12-03 2002-11-10 Kyoto Pharma Ind Heterocyclic compounds and pharmaceutical compositions containing the same
US20020037897A1 (en) 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
YU94203A (sh) * 2001-05-29 2006-08-17 Kyoto Pharmaceutical Industries Ltd. Novi heterociklični derivati i njihova upotreba u medicini

Also Published As

Publication number Publication date
AR036036A1 (es) 2004-08-04
TWI297008B (en) 2008-05-21
JPWO2002096880A1 (ja) 2004-09-09
US7557123B2 (en) 2009-07-07
CZ20033450A3 (cs) 2004-05-12
CN1527819A (zh) 2004-09-08
KR20040030647A (ko) 2004-04-09
EP1403253A4 (en) 2005-03-30
IL159085A0 (en) 2004-05-12
US20040220215A1 (en) 2004-11-04
CA2448634A1 (en) 2002-12-05
AU2002308889B2 (en) 2007-09-06
MXPA03010811A (es) 2004-02-27
YU94003A (sh) 2006-08-17
RU2003137574A (ru) 2005-05-20
HUP0401862A3 (en) 2009-03-30
PL367639A1 (en) 2005-03-07
KR20080093076A (ko) 2008-10-17
WO2002096880A1 (fr) 2002-12-05
HK1069385A1 (en) 2005-05-20
RU2299197C2 (ru) 2007-05-20
NZ530358A (en) 2005-04-29
CO5540342A2 (es) 2005-07-29
NO326688B1 (no) 2009-01-26
EP1403253A1 (en) 2004-03-31
KR100898358B1 (ko) 2009-05-20
CN1242994C (zh) 2006-02-22
HUP0401862A2 (hu) 2004-12-28
BR0209711A (pt) 2004-11-03
ZA200309757B (en) 2004-12-22
JP4279136B2 (ja) 2009-06-17

Similar Documents

Publication Publication Date Title
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
NO20055246D0 (no) Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav
NO20014135D0 (no) Nye sulfonamidforbindelser og deres anvendelse
NO20022289D0 (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20033002L (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
IS8392A (is) Heterósýklískir hindrar MEK og notkun þeirra
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
NO20022600D0 (no) Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS7577A (is) Arómatísk súlfón og læknisfræðileg notkun þeirra
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees